Post-transplant cyclophosphamide pharmacokinetics and haploidentical hematopoietic cell transplantation outcomes: an exploratory study

被引:5
作者
Kasudhan, Kripa Shanker [1 ]
Patil, Amol N. [1 ]
Jandial, Aditya [2 ]
Khadwal, Alka [2 ]
Prakash, Gaurav [2 ]
Jain, Arihant [2 ]
Bhurani, Dinesh [3 ]
Ahmed, Rayaz [3 ]
Agrawal, Narendra [3 ]
Singh, Reema [3 ]
Sachdeva, Man Updesh Singh [4 ]
Varma, Neelam [4 ]
Das, Reena [4 ]
Verma Attri, Savita [5 ]
Malhotra, Samir [1 ]
Majhail, Navneet S. [6 ]
Malhotra, Pankaj [2 ]
Lad, Deepesh P. [2 ]
机构
[1] Postgrad Inst Med Educ & Res, Dept Clin Pharmacol, Chandigarh, India
[2] Postgrad Inst Med Educ & Res, Dept Clin Hematol & Med Oncol, Chandigarh, India
[3] Rajiv Gandhi Canc Inst & Res Ctr, Dept Hematooncol, New Delhi, India
[4] Postgrad Inst Med Educ & Res, Dept Hematol, Chandigarh, India
[5] Postgrad Inst Med Educ & Res, Dept Pediat, Chandigarh, India
[6] Cleveland Clin, Dept Hematol Oncol, Blood & Marrow Transplant Program, Cleveland, OH USA
关键词
PTCy; pharmacokinetics; CEPM; GVHD; haplo-HCT; VERSUS-HOST-DISEASE; DRUG-METABOLIZING-ENZYMES; POLYMORPHISMS; SURVIVAL; GVHD; TOXICITY; REGIMEN; RELAPSE; PLASMA;
D O I
10.1080/10428194.2022.2087067
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Pharmacokinetics of cyclophosphamide has been explored to optimize conditioning dosing. We hypothesized that post-transplant cyclophosphamide (PTCy) metabolite carboxy-ethyl phosphoramide mustard (CEPM) pharmacokinetics might impact haploidentical transplantation (haplo-HCT) outcomes. CEPM area under the curve (AUC(0-48)) was determined by eleven sampling timepoints on day +3/+4 using LC-MS/MS. The median CEPM AUC(0-48) in a cohort of 30 patients was 14.2 (14) mg center dot hr/L. The incidence of severe chronic graft-versus-host disease (GVHD) (73% vs. 11%, p = 0.02), and GVHD-/relapse-free survival (GRFS) was significantly inferior in the CEPM AUC(0-48) < 14 mg center dot hr/L group (54 days vs. 344 days, p = 0.02). There was, however, no difference in grade III-IV acute GVHD (38% vs. 14%, p = 0.12) and overall survival (295 days vs. not reached, p = 0.2). CEPM AUC(0-48,) is associated with severe chronic GVHD and GRFS post-haplo-HCT in this exploratory study. There is scope for personalizing day + 4 PTCy dose based on day + 3 CEPM AUC(0-8).
引用
收藏
页码:2679 / 2685
页数:7
相关论文
共 50 条
[41]   EASIX predicts non-relapse mortality after haploidentical transplantation with post-transplant cyclophosphamide [J].
Mariotti, Jacopo ;
Magri, Filippo ;
Giordano, Laura ;
De Philippis, Chiara ;
Sarina, Barbara ;
Mannina, Daniele ;
Taurino, Daniela ;
Santoro, Armando ;
Bramanti, Stefania .
BONE MARROW TRANSPLANTATION, 2023, 58 (03) :247-256
[42]   Dose-adapted post-transplant cyclophosphamide for HLA-haploidentical transplantation in Fanconi anemia [J].
Thakar, M. S. ;
Bonfim, C. ;
Walters, M. C. ;
Storb, R. ;
Pasquini, R. ;
Burroughs, L. ;
Sandmaier, B. M. ;
Woolfrey, A. ;
Kiem, H-P .
BONE MARROW TRANSPLANTATION, 2017, 52 (04) :570-573
[43]   Myeloablative and reduced-intensity conditioning in HLA-haploidentical peripheral blood stem cell transplantation using post-transplant cyclophosphamide [J].
Sugita, Junichi ;
Kagaya, Yusuke ;
Miyamoto, Toshihiro ;
Shibasaki, Yasuhiko ;
Nagafuji, Koji ;
Ota, Shuichi ;
Furukawa, Tatsuo ;
Nara, Miho ;
Akashi, Koichi ;
Taniguchi, Shuichi ;
Harada, Mine ;
Matsuo, Keitaro ;
Teshima, Takanori .
BONE MARROW TRANSPLANTATION, 2019, 54 (03) :432-441
[44]   Caspofungin for primary antifungal prophylaxis after T-cell-replete haploidentical stem cell transplantation with post-transplant cyclophosphamide [J].
Mariotti, Jacopo ;
De Philippis, Chiara ;
Bramanti, Stefania ;
Sarina, Barbara ;
Tordato, Federica ;
Pocaterra, Daria ;
Casari, Erminia ;
Carlo-Stella, Carmelo ;
Santoro, Armando ;
Castagna, Luca .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2019, 102 (04) :357-367
[45]   Haploidentical haematopoietic stem cell transplantation combined with post-transplant cyclophosphamide in neuronal ceroid lipofuscinosis: Experience in eight patients [J].
Song, Zeliang ;
Cui, Xiaodai ;
Zhang, Zhaoxia ;
Liu, Rong ;
Shi, Xiaodong .
MEDICINA CLINICA, 2024, 162 (05) :244-249
[46]   Impact of Donor Age in Haploidentical-Post-Transplantation Cyclophosphamide versus Matched Unrelated Donor Post-Transplantation Cyclophosphamide Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia [J].
Mehta, Rohtesh S. ;
Ramdial, Jeremy ;
Marin, David ;
Alousi, Amin ;
Kanakry, Christopher G. ;
Champlin, Richard E. ;
Rezvani, Katayoun ;
Shpall, Elizabeth J. ;
Page, Kristin ;
Gadalla, Shahinaz M. ;
Kebriaei, Partow ;
Weisdorf, Daniel .
TRANSPLANTATION AND CELLULAR THERAPY, 2023, 29 (06) :377.e1-377.e7
[47]   Outcomes of Unmanipulated Haploidentical Transplantation Using Post-Transplant Cyclophosphamide (PT-Cy) in Pediatric Patients With Acute Lymphoblastic Leukemia [J].
Ruggeri, Annalisa ;
Galimard, Jacques-Emmanuel ;
Paina, Olesya ;
Fagioli, Franca ;
Tbakhi, Abdelghani ;
Yesilipek, Akif ;
Fernandez Navarro, Jose Maria ;
Faraci, Maura ;
Hamladji, Rose-Marie ;
Skorobogatova, Elena ;
Al-Seraihy, Amal ;
Sundin, Mikael ;
Herrera, Concepcion ;
Rifon, Jose ;
Dalissier, Arnaud ;
Locatelli, Franco ;
Rocha, Vanderson ;
Corbacioglu, Selim .
TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (05) :424.e1-424.e9
[48]   Post-transplant cyclophosphamide in matched donor transplantation: are we there yet? [J].
Lazzari, Lorenzo ;
Catalano, Gloria ;
Bruno, Alessandro ;
Sannipoli, Daniele ;
Lupo-Stanghellini, Maria Teresa ;
Peccatori, Jacopo ;
Ciceri, Fabio ;
Greco, Raffaella .
CURRENT RESEARCH IN TRANSLATIONAL MEDICINE, 2025, 73 (02)
[49]   Early Cardiac Toxicity Associated With Post-Transplant Cyclophosphamide in Allogeneic Stem Cell Transplantation [J].
Dulery, Remy ;
Mohty, Razan ;
Labopin, Myriam ;
Sestili, Simona ;
Malard, Florent ;
Brissot, Eolia ;
Battipaglia, Giorgia ;
Mediavilla, Clemence ;
Banet, Anne ;
Van de Wyngaert, Zoe ;
Paviglianiti, Annalisa ;
Belhocine, Ramdane ;
Isnard, Francoise ;
Lapusan, Simona ;
Adaeva, Rosa ;
Vekhoff, Anne ;
Ledraa, Tounes ;
Legrand, Ollivier ;
Cohen, Ariel ;
Bonnin, Agnes ;
Ederhy, Stephane ;
Mohty, Mohamad .
JACC: CARDIOONCOLOGY, 2021, 3 (02) :250-259
[50]   Allogeneic hematopoietic cell transplantation with cord blood versus mismatched unrelated donor with post-transplant cyclophosphamide in acute myeloid leukemia [J].
Dholaria, Bhagirathbhai ;
Labopin, Myriam ;
Sanz, Jaime ;
Ruggeri, Annalisa ;
Cornelissen, Jan ;
Labussiere-Wallet, Helene ;
Blaise, Didier ;
Forcade, Edouard ;
Chevallier, Patrice ;
Grassi, Anna ;
Zubarovskaya, Ludmila ;
Kuball, Jurgen ;
Ceballos, Patrice ;
Ciceri, Fabio ;
Baron, Frederic ;
Savani, Bipin N. ;
Nagler, Arnon ;
Mohty, Mohamad .
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2021, 14 (01)